Caspofungin (Trilogy Therapeutics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCaspofungin (Trilogy Therapeutics)
Drug Alias Namecaspofungin
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of Action1,3-beta-glucan synthase inhibitors
Targets1,3-beta-glucan synthase
Therapy Area/IndicationsAspergillosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTrilogy Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTrilogy Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAspergillosis

Other Information

ATC CodeN/A
Related LinksN/A